1. Home
  2. BOLT vs FEDU Comparison

BOLT vs FEDU Comparison

Compare BOLT & FEDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLT
  • FEDU
  • Stock Information
  • Founded
  • BOLT 2015
  • FEDU 2007
  • Country
  • BOLT United States
  • FEDU China
  • Employees
  • BOLT N/A
  • FEDU N/A
  • Industry
  • BOLT Biotechnology: Pharmaceutical Preparations
  • FEDU
  • Sector
  • BOLT Health Care
  • FEDU
  • Exchange
  • BOLT Nasdaq
  • FEDU NYSE
  • Market Cap
  • BOLT 16.8M
  • FEDU 20.0M
  • IPO Year
  • BOLT 2021
  • FEDU 2017
  • Fundamental
  • Price
  • BOLT $0.35
  • FEDU $8.10
  • Analyst Decision
  • BOLT Hold
  • FEDU
  • Analyst Count
  • BOLT 5
  • FEDU 0
  • Target Price
  • BOLT $1.00
  • FEDU N/A
  • AVG Volume (30 Days)
  • BOLT 103.8K
  • FEDU 3.9K
  • Earning Date
  • BOLT 05-12-2025
  • FEDU 12-20-2024
  • Dividend Yield
  • BOLT N/A
  • FEDU 27.40%
  • EPS Growth
  • BOLT N/A
  • FEDU N/A
  • EPS
  • BOLT N/A
  • FEDU 0.12
  • Revenue
  • BOLT $3,638,000.00
  • FEDU $27,971,139.00
  • Revenue This Year
  • BOLT N/A
  • FEDU N/A
  • Revenue Next Year
  • BOLT $77.48
  • FEDU N/A
  • P/E Ratio
  • BOLT N/A
  • FEDU $66.95
  • Revenue Growth
  • BOLT N/A
  • FEDU 141.14
  • 52 Week Low
  • BOLT $0.30
  • FEDU $3.69
  • 52 Week High
  • BOLT $1.34
  • FEDU $22.70
  • Technical
  • Relative Strength Index (RSI)
  • BOLT 45.53
  • FEDU 55.89
  • Support Level
  • BOLT $0.35
  • FEDU $7.30
  • Resistance Level
  • BOLT $0.38
  • FEDU $7.71
  • Average True Range (ATR)
  • BOLT 0.03
  • FEDU 0.35
  • MACD
  • BOLT 0.00
  • FEDU 0.13
  • Stochastic Oscillator
  • BOLT 29.16
  • FEDU 80.29

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About FEDU FOUR SEASONS EDUCATION (CAYMAN) INC SPON ADS EACH REP 10 ORD SHS(R/S)

Four Seasons Education (Cayman) Inc is engaged in the provision of after-school education services for kindergarten, elementary and middle school students. The Company derives its revenue from learning services, tourism services, and learning technology and content solutions. The company is a comprehensive educational enterprise that provides research practice services, educational informatization equipment, high-quality educational resources, and teacher training, as well as a digital publishing business, and continues to expand in educational research and educational informatization.

Share on Social Networks: